Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

14.10
Delayed Data
As of 3:59pm ET
 +0.47 / +3.45%
Today’s Change
8.67
Today|||52-Week Range
14.87
+31.78%
Year-to-Date

Today’s Trading

Previous close13.63
Today’s open13.58
Day’s range13.43 - 14.10
Volume868,636
Average volume (3 months)889,483
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+121.51%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio17.2
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.05+0.15%
EBSEmergent BioSolution...+0.04+0.10%
LXRXLexicon Pharmaceutic...+0.15+1.34%
IPXLImpax Laboratories I...-0.45-2.10%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.32
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts